Renal artery stenosis resident survival guide: Difference between revisions
Rim Halaby (talk | contribs) |
|||
(84 intermediate revisions by 2 users not shown) | |||
Line 2: | Line 2: | ||
{{WikiDoc CMG}}; {{AE}} {{KGH}} | {{WikiDoc CMG}}; {{AE}} {{KGH}} | ||
== | ==Overview== | ||
Renal artery stenosis is defined as a dimished diameter of the lumen of the renal artery. | Renal artery stenosis is defined as a dimished diameter of the lumen of the renal artery. | ||
Renal artery of >70% is considered hemodynamically significant.<ref name="pmid23457117">{{cite journal| author=Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH et al.| title=Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2013 | volume= 127 | issue= 13 | pages= 1425-43 | pmid=23457117 | doi=10.1161/CIR.0b013e31828b82aa | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23457117 }} </ref> | Renal artery of >70% is considered hemodynamically significant.<ref name="pmid23457117">{{cite journal| author=Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH et al.| title=Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2013 | volume= 127 | issue= 13 | pages= 1425-43 | pmid=23457117 | doi=10.1161/CIR.0b013e31828b82aa | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23457117 }} </ref> | ||
Line 8: | Line 8: | ||
==Causes== | ==Causes== | ||
===Life Threatening Causes=== | ===Life Threatening Causes=== | ||
Renal artery stenosis | Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Renal artery stenosis does not have life threatening causes. | ||
===Common Causes=== | ===Common Causes=== | ||
*Atherosclerosis | * [[Atherosclerosis]] | ||
*Fibromuscular dysplasia | * [[Fibromuscular dysplasia]] | ||
* [[Neurofibromatosis]] | |||
* [[Vasculitis]] | |||
* [[Congenital|Congenital bands]] | |||
* [[Radiation]] | |||
== | ==Management== | ||
=== | ===Diagnostic Approach=== | ||
Shown below is the diagnostic approach to RAS based on the 2013 AHA Guidelines Recommendations for Management of Patients with PAD.<ref name="pmid23457117">{{cite journal| author=Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH et al.| title=Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2013 | volume= 127 | issue= 13 | pages= 1425-43 | pmid=23457117 | doi=10.1161/CIR.0b013e31828b82aa | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23457117 }} </ref> | |||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | {{familytree | | | | | A01 | |A01='''Determine if one or more of the following is present:''' <br> <div style="float: left; text-align: left; height: 17em; width: 37em; padding:1em;"> ❑ Onset of hypertension before the age of 30 years <br> ❑ Onset of severe hypertension after the age of 55<br> ❑ Accelerated, resistant, or [[malignant hypertension]]<br> ❑ Development of new [[azotemia]] or worsening renal function after administration of an [[ACE inhibitor]] or [[ARB]] agent<br> ❑ Unexplained [[atrophic kidney]] or size discrepancy between kidneys >1.5 cm<br> ❑ Sudden, unexplained pulmonary edema<br> ❑ Unexplained renal dysfunction, including individuals starting renal replacement therapy<br>❑ Multi-vessel [[CAD]]<br> ❑ Unexplained [[CHF]]<br> ❑ Refractory [[angina]] </div>}} | ||
{{familytree | | | | | | | | | | {{familytree | | | | | |!| | | | | | | | | | | | }} | ||
{{familytree | | | | {{familytree | | | | | B01 | | | | | | | B01=<div style="float: left; text-align: left; height: 2em; width: 37em; padding:1em;">❑ Proceed with non-invasive imaging <ref name="pmid21719621">{{cite journal| author=Lao D, Parasher PS, Cho KC, Yeghiazarians Y| title=Atherosclerotic renal artery stenosis--diagnosis and treatment. | journal=Mayo Clin Proc | year= 2011 | volume= 86 | issue= 7 | pages= 649-57 | pmid=21719621 | doi=10.4065/mcp.2011.0181 | pmc=PMC3127560 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21719621 }} </ref><br> </div>}} | ||
{{familytree | | | {{familytree | | | | | |!| | | | | | | | | | | }} | ||
{{familytree | | |!| | | | | | | | | | | | | | | }} | {{familytree | | | | | C01 | | | | | | | | | | | C01=<div style="float: left; text-align: left; height: 1em; width: 37em; padding:1em;">'''Is the patient allergic to contrast?'''</div>}} | ||
{{familytree | | | {{familytree | | |,|-|-|^|-|-|.| | | | | | | | | | }} | ||
{{familytree | | |!| | | | | | | | | | | | | | }} | {{familytree | | C02 | | | | C03 | | | | | | | | | C02= '''Yes'''| C03= '''No'''}} | ||
{{familytree | | | {{familytree | | |!| | | | | |!| | | | | | | | | | }} | ||
{{familytree | | |!| | | | | | | | | | | | | |}} | {{familytree | | |!| | | | | D01 | | | | | | | D01= <div style="float: left; text-align: left; height: 12em; width: 20em; padding:1em;">'''Does the patient has any of the following?'''<br> ❑ Implanted devices:<br> - [[Pacemaker]]s<br> - [[Defibrillator]]s<br> - [[Cochlear implants]]<br> - Spinal cord stimulators <br> ❑ [[Claustrophobia]] </div>}} | ||
{{familytree | | E01 | | | | | | | | | | | E01= ''' | {{familytree | | |!| | | |,|-|^|-|.| | | | | | | |}} | ||
{{familytree | | |!| | | D03 | | D04 | | | | | | | D03= '''No'''| D04= '''Yes'''}} | |||
{{familytree | | |!| | | |!| | | |!| | | | | | | |}} | |||
{{familytree | | E01 | | E02 | | E03 | | | | | | | | | E01=❑ Proceed with [[US]]| E02= ❑ Proceed with [[MRA]] | E03= ❑ Proceed with [[CT]]}} | |||
{{familytree | | |`|-|-|-|+|-|-|-|'| | | | | | |}} | |||
{{familytree | | | | |,|-|^|-|.| | | | | | | | |}} | |||
{{familytree | | | | F01 | | F02 | | | | | | F01= '''Inconclusive noninvasive test but with high clinical index of suspicion:''' <br>❑ Perform [[angiography|catheter angiography]] | F02= '''Confirmed RAS:''' <br> ❑ Proceed to treatment}} | |||
{{familytree/end}} | {{familytree/end}} | ||
<br> | |||
=== Therapeutic Approach=== | |||
Shown below is the diagnostic approach to RAS based on the 2013 AHA Guidelines Recommendations for Management of Patients with PAD.<ref name="pmid23457117">{{cite journal| author=Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH et al.| title=Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2013 | volume= 127 | issue= 13 | pages= 1425-43 | pmid=23457117 | doi=10.1161/CIR.0b013e31828b82aa | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23457117 }} </ref> | |||
| | |||
|- | |||
| | |||
| | |||
|} | |||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | | | | | | | | {{familytree | | | A01 | |A01='''Initiate a regimen that combines:'''<ref name="pmid22279335">{{cite journal| author=Annigeri RA| title=Medical therapy is best for atherosclerotic renal artery stenosis: Arguments for. | journal=Indian J Nephrol | year= 2012 | volume= 22 | issue= 1 | pages= 1-4 | pmid=22279335 | doi=10.4103/0971-4065.91177 | pmc=PMC3263056 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22279335 }} </ref> <br> <div style="float: left; text-align: left; height: 21em; width: 30em; padding:1em;"> ❑ Tight blood pressure control to <130/80 mmHg (120/75 mmHg if proteinuria is present) with: | ||
{{familytree | | | | | | | | | | | ♦ [[ACEI]], or<br> | ||
{{familytree | | | | | | | | ♦ [[ARB]], or<br> | ||
{{familytree | | | | | | | ♦ [[CCB]], or<br> | ||
{{familytree | ♦ [[Beta blockers]] <br> ❑ Control of hyperlipidemia (LDL cholesterol <70 mg/dl) with [[statins]] <br> ❑ Glycemic control (hemoglobin A1c <7%) <br> ❑ [[Antiplatelet]] agents <br> ❑ Life style modifications:<br> | ||
{{familytree | ♦ Smoking cessation counseling | ||
{{familytree | | | | ♦ Normalization of body weight </div>}} | ||
</div>| | {{familytree | | | |!| | | | | | }} | ||
</div>}} | {{familytree | | | B01 | | | | | | | B01= '''Proceed to evaluate clinical indications for revascularization'''}} | ||
{{familytree | | | | {{familytree | | | |!| | | | | | | | }} | ||
{{familytree | | | | {{familytree | | | C01 | | | | | C01= '''Does the patient has any of the following?'''<br> <div style="float: left; text-align: left; height: 19em; width: 30em; padding:1em;"> ❑ RAS with: <br> | ||
- Accelerated, resistant, or [[malignant hypertension]] <br> | |||
- [[Hypertension]] with an unexplained unilateral small kidney <br> | |||
- [[Hypertension]] with medication intolerance <br> ❑ Progressive [[CKD]] with bilateral RAS or RAS to a solitary functioning kidney <br> ❑ Hemodynamically significant RAS with recurrent, unexplained[[CHF]] or sudden, unexplained [[pulmonary edema]] <br> ❑ [[Unstable angina]] <br> ❑ Asymptomatic bilateral or solitary viable kidney <br> ❑ [[Chronic renal failure]] with unilateral RAS </div>}} | |||
{{familytree | | | |!| | | | | | }} | |||
{{familytree | |,|-|^|-|.| | | | }} | |||
{{familytree | D01 | | D02 | | D01='''If any of the above AND:'''<br><div style="float: left; text-align: left; height: 8em; width: 20em; padding:1em;"> ❑ [[Atherosclerosis|Ostial atherosclerotic RAS]], '''OR'''<br> ❑ [[Fibromuscular dysplasia]] </div> | D02= '''If any of the above AND:''' <br><div style="float: left; text-align: left; height: 8em; width: 20em; padding:1em;"> ❑ Complex [[fibromuscular dysplasia]] disease that extends into segmental arteries, '''OR''' <br> ❑ [[Aneurysm|Macroaneurysms]], '''OR''' <br> ❑ [[Atherosclerosis|Atherosclerotic]] RAS with multiple small renal arteries or early primary branching of the main [[renal artery]]</div> }} | |||
{{familytree | |!| | | |!| | | | | }} | |||
{{familytree | E01 | | E02 | E01=Endovascular treatment | E02=Renal artery surgery }} | |||
{{familytree/end}} | {{familytree/end}} | ||
==References== | ==References== |
Latest revision as of 00:25, 13 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karol Gema Hernandez, M.D. [2]
Overview
Renal artery stenosis is defined as a dimished diameter of the lumen of the renal artery. Renal artery of >70% is considered hemodynamically significant.[1]
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Renal artery stenosis does not have life threatening causes.
Common Causes
Management
Diagnostic Approach
Shown below is the diagnostic approach to RAS based on the 2013 AHA Guidelines Recommendations for Management of Patients with PAD.[1]
Determine if one or more of the following is present: ❑ Onset of hypertension before the age of 30 years ❑ Onset of severe hypertension after the age of 55 ❑ Accelerated, resistant, or malignant hypertension ❑ Development of new azotemia or worsening renal function after administration of an ACE inhibitor or ARB agent ❑ Unexplained atrophic kidney or size discrepancy between kidneys >1.5 cm ❑ Sudden, unexplained pulmonary edema ❑ Unexplained renal dysfunction, including individuals starting renal replacement therapy ❑ Multi-vessel CAD ❑ Unexplained CHF ❑ Refractory angina | |||||||||||||||||||||||||||||||||||||||
❑ Proceed with non-invasive imaging [2] | |||||||||||||||||||||||||||||||||||||||
Is the patient allergic to contrast? | |||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||
Does the patient has any of the following? ❑ Implanted devices: - Pacemakers - Defibrillators - Cochlear implants - Spinal cord stimulators ❑ Claustrophobia | |||||||||||||||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||||||||||||||
❑ Proceed with US | ❑ Proceed with MRA | ❑ Proceed with CT | |||||||||||||||||||||||||||||||||||||
Inconclusive noninvasive test but with high clinical index of suspicion: ❑ Perform catheter angiography | Confirmed RAS: ❑ Proceed to treatment | ||||||||||||||||||||||||||||||||||||||
Therapeutic Approach
Shown below is the diagnostic approach to RAS based on the 2013 AHA Guidelines Recommendations for Management of Patients with PAD.[1]
Initiate a regimen that combines:[3] ❑ Tight blood pressure control to <130/80 mmHg (120/75 mmHg if proteinuria is present) with:
♦ ACEI, or | |||||||||||||||||||||||
Proceed to evaluate clinical indications for revascularization | |||||||||||||||||||||||
Does the patient has any of the following? ❑ RAS with: - Accelerated, resistant, or malignant hypertension ❑ Progressive CKD with bilateral RAS or RAS to a solitary functioning kidney ❑ Hemodynamically significant RAS with recurrent, unexplainedCHF or sudden, unexplained pulmonary edema ❑ Unstable angina ❑ Asymptomatic bilateral or solitary viable kidney ❑ Chronic renal failure with unilateral RAS | |||||||||||||||||||||||
If any of the above AND: | If any of the above AND: ❑ Complex fibromuscular dysplasia disease that extends into segmental arteries, OR ❑ Macroaneurysms, OR ❑ Atherosclerotic RAS with multiple small renal arteries or early primary branching of the main renal artery | ||||||||||||||||||||||
Endovascular treatment | Renal artery surgery | ||||||||||||||||||||||
References
- ↑ 1.0 1.1 1.2 Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH; et al. (2013). "Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. 127 (13): 1425–43. doi:10.1161/CIR.0b013e31828b82aa. PMID 23457117.
- ↑ Lao D, Parasher PS, Cho KC, Yeghiazarians Y (2011). "Atherosclerotic renal artery stenosis--diagnosis and treatment". Mayo Clin Proc. 86 (7): 649–57. doi:10.4065/mcp.2011.0181. PMC 3127560. PMID 21719621 Check
|pmid=
value (help). - ↑ Annigeri RA (2012). "Medical therapy is best for atherosclerotic renal artery stenosis: Arguments for". Indian J Nephrol. 22 (1): 1–4. doi:10.4103/0971-4065.91177. PMC 3263056. PMID 22279335.